Data is not available at this time.
Platz Co., Ltd. operates in Japan's medical and nursing care equipment sector, specializing in the production and distribution of care beds, mattresses, and related accessories. The company serves a niche market, supplying retailers of medical devices, nursing care goods, and furniture shops. Its product portfolio includes nursing care beds, hospital beds, and reclining beds, catering primarily to healthcare facilities and elderly care providers. Platz Co. maintains a focused presence in Japan, leveraging its expertise in ergonomic and functional care solutions. The company’s market positioning is reinforced by its long-standing industry presence, having been incorporated in 1992 and rebranded in 1995. While it operates in a competitive segment dominated by larger medical equipment manufacturers, Platz Co. differentiates itself through specialized product offerings and localized distribution channels. The aging population in Japan presents a steady demand driver for its products, though the company faces challenges from pricing pressures and evolving regulatory standards in the healthcare sector.
For the fiscal year ending June 2024, Platz Co. reported revenue of ¥6.39 billion, with net income of ¥65.7 million, reflecting modest profitability. The diluted EPS stood at ¥18.52, indicating limited earnings power relative to its market capitalization. Operating cash flow was ¥392.4 million, while capital expenditures were minimal at ¥29.3 million, suggesting restrained reinvestment in growth initiatives.
The company’s earnings power appears constrained, with net income representing a slim margin of approximately 1% of revenue. Operating cash flow, though positive, does not significantly exceed capital expenditures, indicating limited free cash flow generation. The balance between debt and cash reserves suggests a cautious approach to leveraging, with total debt nearly matching cash and equivalents.
Platz Co. holds ¥2.06 billion in cash and equivalents against ¥2.1 billion in total debt, resulting in a near-neutral net debt position. This balance sheet structure implies moderate financial flexibility, though the high debt load relative to earnings could pose risks if profitability further declines. The absence of aggressive leverage suggests a conservative financial strategy.
Growth trends appear subdued, with no significant capital expenditure activity signaling expansion. The company pays a dividend of ¥14 per share, offering a modest yield, likely appealing to income-focused investors. However, the lack of robust revenue or earnings growth limits the potential for dividend increases in the near term.
With a market capitalization of ¥2.61 billion, Platz Co. trades at a price-to-sales ratio of approximately 0.4x, reflecting subdued market expectations. The low beta of 0.486 suggests relative stability but also limited alignment with broader market movements, typical for niche healthcare equipment providers.
Platz Co.’s strategic advantages lie in its specialized product line and entrenched position in Japan’s care equipment market. However, the outlook remains cautious due to competitive pressures and demographic reliance on an aging population. The company’s ability to innovate or expand beyond its core market will be critical for long-term sustainability.
Company filings, market data
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |